Patients With Atrial Fibrillation and Outcomes of Cerebral Infarction in Those With Treatment of Warfarin Versus No Warfarin With References to CHA2DS2-VASc Score, Age and Sex - A Swedish Nationwide Observational Study With 48 433 Patients

PLoS ONE - United States
doi 10.1371/journal.pone.0176846
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

JAMA Cardiology
Cardiovascular MedicineCardiology
2016English

PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

Archives of Internal Medicine
2012English

Inverse Correlation Between Left Atrial Appendage Function and CHA2DS2-VASc Score in Patients With Atrial Flutter

Scientific Reports
Multidisciplinary
2019English

CHADS2 score Has a Better Predictive Value Than CHA2DS2-VASc Score in Elderly Patients With Atrial Fibrillation

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2016English

Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes

Canadian Journal of Kidney Health and Disease
Nephrology
2017English

Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy